We are live on ! Find out more
NRS

Neville Rodie & Shaw Portfolio holdings

AUM $1.55B
1-Year Est. Return 46.95%
This Fund
S&P 500
This Quarter Est. Return
+8.88%
1 Year Est. Return
+46.95%
3 Year Est. Return
+114.59%
5 Year Est. Return
+149.24%
10 Year Est. Return
+498%
AUM
$1.02B
AUM Growth
+$74.7M
Cap. Flow
-$986K
Cap. Flow %
-0.1%
Top 10 Hldgs %
31.61%
Holding
254
New
10
Increased
66
Reduced
77
Closed
4

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$5.43M
2
QCOM icon
Qualcomm
QCOM
+$1.65M
3
BX icon
Blackstone
BX
+$1.52M
4
DIS icon
Walt Disney
DIS
+$869K
5
ZTS icon
Zoetis
ZTS
+$790K

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$9.24M
2
BA icon
Boeing
BA
+$1.45M
3
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
+$1.35M
4
XOM icon
ExxonMobil
XOM
+$1.3M
5
AGN
Allergan plc
AGN
+$1.01M

Sector Composition

Rank Sector Weight
1 Healthcare 20.13%
2 Technology 16.35%
3 Financials 15.15%
4 Industrials 12.69%
5 Energy 8.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HON icon
26
Honeywell
HON
$78B
$11.2M 1.1%
67,173
+2,779
+4% +$454K
BMY icon
27
Bristol-Myers Squibb
BMY
$132B
$11.1M 1.09%
173,259
+94,799
+121% +$5.43M
LRCX icon
28
Lam Research
LRCX
$390B
$11M 1.08%
375,080
-2,770
-0.7% -$73.6K
J icon
29
Jacobs Solutions
J
$17B
$10.8M 1.06%
145,165
-1,632
-1% -$124K
UNP icon
30
Union Pacific
UNP
$174B
$10.6M 1.04%
58,691
+787
+1% +$135K
UNH icon
31
UnitedHealth
UNH
$370B
$10.5M 1.03%
35,606
-210
-0.6% -$54.9K
CVX icon
32
Chevron
CVX
$366B
$9.8M 0.96%
81,306
-1,743
-2% -$205K
ORCL icon
33
Oracle
ORCL
$423B
$9.44M 0.93%
178,188
+554
+0.3% +$30.5K
PWR icon
34
Quanta Services
PWR
$101B
$9.42M 0.92%
231,315
+4,550
+2% +$186K
BX icon
35
Blackstone
BX
$110B
$9.37M 0.92%
167,434
+29,374
+21% +$1.52M
META icon
36
Meta Platforms (Facebook)
META
$1.51T
$8.96M 0.88%
43,677
+837
+2% +$162K
PEP icon
37
PepsiCo
PEP
$190B
$8.68M 0.85%
63,475
+1,575
+3% +$214K
AXP icon
38
American Express
AXP
$230B
$8.6M 0.84%
69,103
-150
-0.2% -$17.9K
XLY icon
39
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$23.2B
$8.53M 0.84%
135,958
+12,406
+10% +$755K
EMR icon
40
Emerson Electric
EMR
$88.3B
$8.31M 0.82%
109,016
-150
-0.1% -$10.8K
VZ icon
41
Verizon
VZ
$196B
$8.08M 0.79%
131,627
+4,727
+4% +$285K
CVS icon
42
CVS Health
CVS
$122B
$7.87M 0.77%
105,963
+7,050
+7% +$495K
ABBV icon
43
AbbVie
ABBV
$435B
$7.59M 0.74%
85,744
-75
-0.1% -$6.23K
IBB icon
44
iShares Biotechnology ETF
IBB
$9.77B
$7.45M 0.73%
61,802
-1,150
-2% -$128K
CRM icon
45
Salesforce
CRM
$158B
$7.36M 0.72%
45,231
+2,075
+5% +$325K
COST icon
46
Costco
COST
$420B
$7.22M 0.71%
24,573
+336
+1% +$99.9K
PFE icon
47
Pfizer
PFE
$153B
$6.42M 0.63%
172,761
-10,013
-5% -$357K
AGN
48
DELISTED
Allergan plc
AGN
$6.31M 0.62%
33,012
-5,625
-15% -$1.01M
IBM icon
49
IBM
IBM
$224B
$6.3M 0.62%
49,183
-165
-0.3% -$21.4K
ADP icon
50
Automatic Data Processing
ADP
$108B
$6.3M 0.62%
36,937
+58
+0.2% +$9.6K
1
2
3 4 5

Similar funds

BGCP
Bristol Gate Capital Partners Toronto, Ontario, Canada $1.55B AUM 12.75% 1-Year Est. Return
MSA
MUFG Securities Americas New York $1.55B AUM 28.4% 1-Year Est. Return
CET
Clean Energy Transition London, United Kingdom $1.54B AUM 34.41% 1-Year Est. Return
ICM
Irenic Capital Management New York $1.54B AUM 12.79% 1-Year Est. Return
CCM
Cinctive Capital Management New York $1.53B AUM 48.83% 1-Year Est. Return
TNBTD
Trustmark National Bank Trust Department Jackson, Mississippi $1.56B AUM 16.53% 1-Year Est. Return
MCP
Meridiem Capital Partners Dallas, Texas $1.53B AUM 17.03% 1-Year Est. Return
SG
Sienna Gestion Paris, France $1.53B AUM 27.73% 1-Year Est. Return

Neville Rodie & Shaw's Q4 2019 Portfolio in Review

As of Q4 2019, Neville Rodie & Shaw held 254 positions worth $1.02B, up 7.9% from $945M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Neville Rodie & Shaw's Q4 2019 filing shows 10 new, 66 increased, 77 reduced and 4 closed positions. Its largest new stake was Qualcomm: 19,730 shares worth $1.74M. The largest sale was Celgene Corp, an estimated $9.24M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 20% a quarter earlier, followed by Technology and Financials.

  • Neville Rodie & Shaw's largest Q4 2019 buy was Qualcomm: 19,730 shares worth $1.74M.
  • Neville Rodie & Shaw added most to Bristol-Myers Squibb in Q4 2019, an estimated $5.43M increase.
  • Neville Rodie & Shaw's biggest Q4 2019 reduction was Boeing, cutting an estimated $1.45M.
  • Neville Rodie & Shaw fully exited Celgene Corp in Q4 2019, selling an estimated $9.24M.
  • Neville Rodie & Shaw's ten largest holdings make up 32% of its $1.02B portfolio in Q4 2019.
  • Neville Rodie & Shaw opened 10 new positions and closed 4 in Q4 2019.
  • Neville Rodie & Shaw's portfolio value rose 7.9% quarter-over-quarter to $1.02B.

Based on Neville Rodie & Shaw's 13F filing for Q4 2019, filed 8 Jan 2020.